ProfileGDS4718 / 1568636_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 19% 11% 18% 12% 15% 19% 18% 21% 19% 19% 15% 12% 17% 20% 21% 16% 17% 17% 15% 21% 17% 24% 18% 19% 17% 23% 15% 23% 18% 22% 18% 20% 16% 21% 11% 10% 18% 13% 15% 12% 16% 16% 16% 19% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.1148419
GSM549102patient 115, normal, homogenized [OPG study]3.8347511
GSM549104patient 119, normal, homogenized [OPG study]4.0338218
GSM549108patient 138, normal, homogenized [OPG study]3.8607312
GSM549119patient 077, normal, homogenized [OPG study]3.9785815
GSM549133patient 032, cancer, homogenized [OPG study]4.0427819
GSM549139patient 042, cancer, homogenized [OPG study]4.0571418
GSM549099patient 107, normal, homogenized [OPG study]4.2077721
GSM549109patient 139, normal, homogenized [OPG study]4.1308919
GSM549110patient 046, normal, homogenized [OPG study]4.1215519
GSM549114patient 063, normal, homogenized [OPG study]3.9462715
GSM549122patient 082, normal, homogenized [OPG study]3.8761112
GSM549134patient 033, cancer, homogenized [OPG study]4.046617
GSM549136patient 036, cancer, homogenized [OPG study]4.0863920
GSM549140patient 044, cancer, homogenized [OPG study]4.1338821
GSM549111patient 047, normal, homogenized [OPG study]3.9892116
GSM549113patient 057, normal, homogenized [OPG study]4.0016417
GSM549132patient 031, cancer, homogenized [OPG study]4.0106817
GSM549137patient 038, cancer, homogenized [OPG study]3.9685815
GSM549142patient 047, cancer, homogenized [OPG study]4.2555921
GSM549100patient 110, normal, homogenized [OPG study]4.0548717
GSM549107patient 135, normal, homogenized [OPG study]4.2551824
GSM549115patient 068, normal, homogenized [OPG study]4.0086518
GSM549116patient 072, normal, homogenized [OPG study]4.0938119
GSM549120patient 078, normal, homogenized [OPG study]4.0338817
GSM549131patient 030, cancer, homogenized [OPG study]4.2000423
GSM549118patient 074, normal, homogenized [OPG study]3.974615
GSM549129patient 027, cancer, homogenized [OPG study]4.2735223
GSM549123patient 088, normal, homogenized [OPG study]4.0753918
GSM549124patient 006, cancer, homogenized [OPG study]4.2473522
GSM549126patient 015, cancer, homogenized [OPG study]4.0577418
GSM549128patient 025, cancer, homogenized [OPG study]4.1056520
GSM549103patient 117, normal, homogenized [OPG study]4.0327616
GSM549117patient 073, normal, homogenized [OPG study]4.1704221
GSM549138patient 041, cancer, homogenized [OPG study]3.8117811
GSM549141patient 045, cancer, homogenized [OPG study]3.7282210
GSM549130patient 028, cancer, homogenized [OPG study]4.0861718
GSM549101patient 111, normal, homogenized [OPG study]3.9002213
GSM549105patient 128, normal, homogenized [OPG study]3.9783215
GSM549106patient 134, normal, homogenized [OPG study]3.8153812
GSM549112patient 048, normal, homogenized [OPG study]3.9984316
GSM549125patient 011, cancer, homogenized [OPG study]4.024316
GSM549127patient 024, cancer, homogenized [OPG study]3.9616716
GSM549135patient 035, cancer, homogenized [OPG study]4.0464919